Skip to main content
SpringerLink
Log in

Radiopharmaceutical Dosimetry in the Treatment of Differentiated Thyroid Carcinoma with I-131

  • Chapter
Progress in Radiopharmacology 3

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 2))

  • 37 Accesses

Abstract

Radiotherapy plans the target to non-target ratio of absorbed radiation energy doses in advance and can fractionate its application at will by external beams and sealed radioactive sources. The dose commitment to a thyroidectomized patient with functioning metastases of differentiated thyroid carcinoma after the administration of various amounts of radioiodide, is not so easily predictable. In this presentation the pharmacokinetics leading to the final distribution of the radiation doses and its consequences will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pochin EE, Profile counting. In: Medical Radioisotope Scanning. Seminar organized by IAEA and WHO International Atomic Energy Agency, Vienna, 1951

    Google Scholar 

  2. Stewart Scott J et al. Measurement of dose to thyroid carcinoma metastases from radioiodine therapy. Brit. J. Radiol. 43: 256, 1970.

    Article  Google Scholar 

  3. Singh B et al. Kinetics of large therapy doses of I-131 in patients with thyroid cancer. J. nuc. Med. 15 /8: 674, 1974.

    CAS  Google Scholar 

  4. Halnan KE, The treatment of thyroid cancer. Ann. Radiol. 20 /8: 826, 1977.

    PubMed  CAS  Google Scholar 

  5. Sinclair W.K. et al. A quantitative autoradiographic study of radioiodine distribution and dosage in human thyroid glands. Brit. J. Radiol. 31: 36, 1956.

    Article  Google Scholar 

  6. Marcuse H.R. et al. Is a comparison of I-131 treatment results by the deli ed radiation dose practicable? In: Third International Radiopharmaceutica. Dosimetry Symposium. Watson ES et al. (eds), FDA 81–8166, US Dept. of Hea. and Human Services. 595–601.

    Google Scholar 

  7. Delprat CC et al. Retrospective blood radiation dose estimation following therapy with I-131 in thyroid carcinoma. In: Advances in Thyroid Neoplasi, Andreoli M et al. (ed), Field Educational Italy, 1981.

    Google Scholar 

  8. Palmer JA et al, Irradiation as an etiologic factor in tumours of the thyparathyroid and salivary glands. Can. J. Surg. 23 /1: 39, 1980.

    PubMed  CAS  Google Scholar 

  9. Stephen et al F, Irradiation induced salivary gland neoplasia, Ann. Surg. 191–304, 1980.

    Google Scholar 

Download references

Authors
  1. H. R. Marcuse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. C. Delprat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. A. Hoefnagel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. P. M. Jongsma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Maessen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rotterdamsch Radio-Therapeutisch Instituut, Netherlands

    Peter H. Cox (Head Department of Nuclear Medicine, Co-ordinating Chairman Joint Committee on Radiopharmaceuticals of the Society of Nuclear Medicine and the European Nuclear Medicine Society) (Head Department of Nuclear Medicine, Co-ordinating Chairman Joint Committee on Radiopharmaceuticals of the Society of Nuclear Medicine and the European Nuclear Medicine Society)

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Marcuse, H.R., Delprat, C.C., Hoefnagel, C.A., Jongsma, A.P.M., Maessen, H. (1982). Radiopharmaceutical Dosimetry in the Treatment of Differentiated Thyroid Carcinoma with I-131. In: Cox, P.H. (eds) Progress in Radiopharmacology 3. Developments in Nuclear Medicine, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7669-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7669-6_11

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7671-9

  • Online ISBN: 978-94-009-7669-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation